Asset Details
Do you wish to reserve the book?
Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients
Do you wish to request the book?
Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients
2016
Overview
Background
Matrixmetalloproteinases (MMPs) comprise a family of zinc-dependent endopeptidases which are involved in angiogenesis, tumor invasion and metastatic formation. Up to date, the prognostic relevance of MMPs in serum of patients with colon cancer remains unknown. Thus, we wanted to assess an expression pattern of MMPs in a homogenous cohort of colon cancer patients to assess their potential as prognostic biomarkers.
Methods
Differences in the expression pattern of MMP7, MMP10 and MMP12 in 78 serum specimens of patients with an adenocarcinoma of the colon and serum specimens of a healthy control group were assessed using Luminex-100 technologies. Subsequently, we correlated these results with histopathological and clinical data of the patients.
Results
Luminex based expression analysis revealed a significant overexpression of MMP7 and an overexpression of MMP10 and MMP12 in the sera of colon cancer patients compared to the healthy control group. Patients with vascular invasion showed a significantly higher MMP12 expression than V0-staged patients. Moreover overexpression of MMP7, MMP10 and MMP12 in colon cancer patients´ sera displayed a significantly impaired overall survival. Multivariate analysis revealed high MMP10 serum levels to be an independent adverse prognostic marker in colon cancer patients.
Conclusions
Expression patterns of MMP7, MMP10 and MMP12 in colon cancer patients´ sera are different compared to serum specimens of healthy individuals. Furthermore, overexpression of MMP7, MMP10 and MMP12 in colon cancer patients´ sera correlates with a dismal prognosis and may help to stratify patients into different risk groups.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V
Subject
/ Biomedical and Life Sciences
/ Cancer
/ Colonic Neoplasms - diagnosis
/ Colonic Neoplasms - pathology
/ Complications and side effects
/ Female
/ Health Promotion and Disease Prevention
/ Humans
/ Male
/ Matrix Metalloproteinase 10 - blood
/ Matrix Metalloproteinase 12 - blood
/ Matrix Metalloproteinase 7 - blood
/ Oncology
/ Proteins
/ Surgery
